People on retatrutide in clinical trials experienced a decrease in total body fat mass by as much as 26.1%, while others lost up to 6.5 kg of lean mass
doi: 10.1016/j.imlet.2019.10.009 54 AhlbergEMartiMGovindarajDSeverinEDuchenKJenmalmMCet al
Formulary Tier Placement On the 2025-2026 BCBSNC commercial formulary, Wegovy sits on Tier 4 (specialty) for most plans, though some Blue Value and Blue Local plans place it on Tier 3 (non-preferred brand)
A bubble sitting in the middle of your liquid column means you are injecting air plus less-than-intended tirzepatide
Phase 3 clinical trials are ongoing, with additional data expected throughout 2026
He writes the internationally-read blog, The Healthy Addiction and lives in Tucson, Arizona with his wife, Marie, and dog, Asher.